Outsourcing Pharma

JANUARY 3, 2022

An R&D leader from the explains its proactive approach to staying on top of supply chain challenges, including a new dedicated manufacturing line in China.

87

87

pharmaphorum

JANUARY 3, 2022

Shares in Applied Therapeutics slumped today after it said it would have to delay a US filing for its lead drug programme AT-007, following an FDA request for more data. The New York-based biopharma company had been hoping to file AT007 in its lead indication galactosaemia in the third quarter of last year, but said it will now have to wait for results from an ongoing phase 3 trial.

FDA 59

FDA Labelling 59

Outsourcing Pharma

JANUARY 3, 2022

A representative from IFF Pharma Solutions talks about significant challenges in drug development and improvements the industry can implement to overcome them.

69

69

Pharma Mirror

JANUARY 3, 2022

Healthcare professionals who comply with the Health Insurance Portability and Accountability Act (HIPAA) will benefit by removing the risk of breaching the HIPAA rules. Their patients would feel secure with them. They won’t be at risk of losing their license. They will also benefit from the continued business they’ll get from hospitals that require compliant professionals.

HIPAA 52

HIPAA Insurance Hospitals 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Outsourcing Pharma

JANUARY 3, 2022

A leader from the clinical trial technology company says that insights gained during the recent pandemic could be helpful in realizing future improvements.

59

59

Roots Analysis

JANUARY 3, 2022

In the era of COVID-19, where the world is looking for point of care treatment, in order to avoid maintain physical distance. Post the onset of COVID-19 pandemic, there has been a decline in number of patients visiting laboratories for sample collection and testing. To avoid risk of infections, patients have postponed their routine tests and medical checkups.

52

52